AA001 / Shenzhen Zhiyuan Biomedical - LARVOL DELTA

Clinical Evaluation of an AI-Assisted Decision Support System for General Anesthesia Management Based on Data From 6 Centers: Comparative Study. (PubMed, J Med Internet Res) - "The AI-assisted decision support system demonstrated varying levels of concordance with anesthesiologists in managing surgery, with the highest agreement observed in propofol administration. However, the system's lower agreement in hemodynamic medication management highlights the need for further optimization and validation. These findings underscore the potential of AI systems to enhance anesthetic decision-making, improve efficiency, and address workforce challenges in anesthesiology. Future research should focus on expanding the system's capabilities, validating its performance in prospective clinical trials, and ensuring its integration into diverse clinical settings."

Clinical • Journal • Retrospective data • Anesthesia

Leuconostoc mesenteroides AA001: A High-Efficiency Nitrite Degrader Facilitating Controlled and Safe Traditional Vegetable Fermentation. (PubMed, Microorganisms) - "Microbial community profiling throughout fermentation revealed that early dominance by this strain rapidly established a lactic acid-driven anaerobic environment, effectively suppressing nitrite-accumulating microorganisms and steering the process toward a stable, safe, and flavor-consistent trajectory. Thus, L. mesenteroides AA001 is a safe starter strain that combines potent nitrite-degrading capacity with fermentation-guiding functionality, effectively ensuring safety and process controllability in traditional vegetable fermentation."

Journal

A Phase Ib, Randomized, Double-blind, Placebo-controlled, Dose-escalation Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of AA001 Monoclonal Antibody in Chinese Patients with Mild Alzheimer's Disease and Alzheimer's Disease-Related Mild Cognitive Impairment. (ChiCTR) - P1 | N=36 | Not yet recruiting | Sponsor: Xuanwu Hospital, Capital Medical University; Xuanwu Hospital, Capital Medical University

New P1 trial • Alzheimer's Disease • CNS Disorders • Cognitive Disorders